Independence Bank of Kentucky’s Quest Diagnostics DGX Stock Holding History

Independence Bank of Kentucky’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.2K	Sell	100 -100	-50%	-$19.6K	﹤0.01%	463
2026 Q1	$39.2K	Hold	200	–	–	0.01%	428
2025 Q4	$34.7K	Hold	200	–	–	﹤0.01%	438
2025 Q3	$38.1K	Hold	200	–	–	﹤0.01%	434
2025 Q2	$35.9K	Hold	200	–	–	0.01%	429
2025 Q1	$33.8K	Hold	200	–	–	0.01%	425
2024 Q4	$30.2K	Hold	200	–	–	﹤0.01%	445
2024 Q3	$31.1K	Buy	200 +100	+100%	+$14.9K	0.01%	411
2024 Q2	$13.7K	Hold	100	–	–	﹤0.01%	434
2024 Q1	$13.3K	Hold	100	–	–	﹤0.01%	426
2023 Q4	$13.8K	Buy	+100	New	+$13.1K	﹤0.01%	404

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Independence Bank of Kentucky's DGX Position: Q2 2026 in Review

Independence Bank of Kentucky reduced its Quest Diagnostics (DGX) stake by 50% in Q2 2026, selling an estimated $19.6K and leaving 100 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Independence Bank of Kentucky first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. The position peaked at $39.2K in Q1 2026. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Independence Bank of Kentucky held 100 shares of Quest Diagnostics worth $21.2K as of Q2 2026.
Independence Bank of Kentucky sold 100 Quest Diagnostics shares in Q2 2026, an estimated $19.6K.
Quest Diagnostics made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #463 holding.
Independence Bank of Kentucky first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
Independence Bank of Kentucky's Quest Diagnostics position peaked at $39.2K in Q1 2026.
629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.